Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (45)FDA ODAC recommends Truqap in prostate cancer
Preheader (108)Truqap recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
Typography
Arial
Colors
Text Analysis
Body Words139
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px788 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEvening

FDA ODAC recommends Truqap in prostate cancer

Truqap recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
FDA ODAC recommends Truqap in prostate cancer